Bergman Alan B. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Bergman Alan B. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Profile

Bergman Alan B.

Alan B. Bergman is the Chief Financial Officer of 20/20 Biolabs, Inc. He has held this position since at least 2026, as indicated by the most recent SEC filing. His role typically involves overseeing the financial operations and strategy of the company.

RoleChief Financial Officer
Notability10/100

Board memberships

Frequently Asked Questions

Who is Bergman Alan B.?

Alan B. Bergman is the Chief Financial Officer of 20/20 Biolabs, Inc. He has held this position since at least 2026, as indicated by the most recent SEC filing. His role typically involves overseeing the financial operations and strategy of the company.…

Where can I see all of Bergman Alan B.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Bergman Alan B. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.